Endo International (ENDP) said Monday it has agreed to pay $8.05 billion to private equity firm TPG to buy Par Pharmaceutical Holdings, a deal aimed at expanding its growing generics business.
The stock-and-cash deal, approved by the boards of both companies, will create one of "the top five" generics manufacturers in terms of U.S. sales, Endo said.
17:10 U.C. Berkeley Adds 'Game of Thrones' Dothraki Language Course14
23:59 Shares in Takata suspended after reported bankruptcy filing plan18
19:56 The Fate Of The Furious Will Be The 30th Movie To Make A Billion Dollars — See The Hit List HERE!21
10:18 Chevron to sell Bangladesh gas fields to Chinese co24